Code Context <!--END NAVBAR-->
<?php
if ($page == 'home'): {
$viewFile = '/mnt/persist/www/ihipo.com/app/View/Layouts/frontend.ctp'
$dataForView = array(
'userData' => null,
'job' => array(
'Job' => array(
'id' => '1897',
'name' => 'Country Manager – United Kingdom',
'overview' => 'Torrent Pharmaceuticals Ltd. (India) / Torrent Pharma GmbH (Germany)
Torrent Pharma GmbH is a wholly owned subsidiary of Torrent pharmaceuticals Limited (TPL) which is a flagship company of ca. EUR 870 million Torrent group in Ahmedabad India. Torrent group is diversified into electrical power and pharmaceuticals.
TPL is a branded generic company manufacturing and selling pharmaceutical products achieving an annual turnover of around EUR 250 million.
R&D capabilities: Invested over EUR 35 million in a modern well equipped state of art research center housing over 600 scientists working on the below mentioned areas of research.
o New Drug Discovery Research (discovering new molecules in niche therapeutic areas)
o New Drug Delivery Systems (proprietary technologies to make value added super generics)
o Generic development (Formulation development and API synthesis, Proven capability to develop non-infringing route and non-infringing formulation)
o BE Centre (state of art Bio-Equivalence centre with 56 beds approved by ANVISA (Brazil) and soon expected to be approved by USFDA and European Health authorities)
Registration capabilities: Highly experienced regulatory team in Germany to support our customers in EU with their dossier registrations strongly backed by an extensive team in India; also providing the flexibility to audit the registration dossiers within EU (Nürnberg, Germany)
Manufacturing capabilities: Our manufacturing facilities (API and formulation), located near Ahmedabad (India), are approved by USFDA and cGMP certified by various authorities including Germany, MHRA (UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
Marketing Presence in Indian Market: Branded Generics company manufacturing and selling pharmaceutical products, achieving an annual turnover of ca. EUR 150 million. Ranked 7th in domestic Rx market; with a field force of over 2200 medical representatives covering over 200,000 doctors. We have a dominant position in therapeutic areas of CNS, CVS (including metabolic disorder), GI, Anti-Microbial, Anti-diabetics, Analgesics and Anti-Inflammatory.
Marketing Presence in International Markets: Exports to more than 70 countries around the world with over 1000 product registrations world wide; wholly owned subsidiaries in USA, Germany, Brazil, Philippines and Russia; own field operations in Germany, Russia & CIS, Lithuania, Brazil, Africa and south east Asia.
We offer:
(1) Product Licensing Co-operation:
- EU CTD registration dossiers with BE studies conducted against EU originator reference, in GCP-GLP certified labs
- Marketing authorizations in key EU countries via national, MRP, DCP procedures
- Supply of products from EU approved (API + Formulation) facilities; vertical integration for most products
- Attractive basket of products in CNS, CVS, GI, GU etc…
(2) New Drug Delivery Systems (NDDS) for value added generics
- Developed unique NDDS platforms which would help to extend the lifespan of existing products.
- Proprietary technology platforms like DuReIn tech, ComTab tech, Gastro Retentive System
- Non Proprietary technology platforms like Taste masking particles, Bi-layered tablets, Mouth dissolving tablets to address needs of patients.
- Novel, Attractive solutions like LAM disp OD formulation – first time in world
(3) Manufacturing Capabilities (Contract Manufacturing)
- Manufacturing facilities (API and formulation) approved by USFDA and cGMP certified by various authorities including Germany, MHRA(UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
- Available capacity of 6 billion tabs / caps / vials per annum
(4) API development and production
- Proven Skills in Medicinal Chemistry, development of non-infringing routes and preparation / submission of DMFs
- R&D Centre well equipped for process development, scale-up and transfer to plant scale production
- Expertise in developing niche APIs, Specially high value, low volume products
- EU approved API manufacturing facilities; capacities being further expanded
Hence in short, we offer you a “one stop shop',
'date_add' => null,
'company_id' => '2286',
'specialization_id' => null,
'language_value_id' => null,
'available_country_id' => '222',
'entryoption_id' => '2',
'slug' => '',
'status' => '1',
'www' => null,
'tags' => null,
'date_exp' => null,
'featured' => '0',
'meta_title' => '',
'meta_description' => ''
),
'Company' => array(
'id' => '2286',
'epid' => '0',
'name' => '',
'industry_id' => null,
'premium' => '0',
'address' => '',
'zip' => '',
'city' => '',
'available_country_id' => '0',
'email' => 'ankurjauhari@torrentpharma.com',
'www' => '',
'overview' => '',
'status' => '0',
'date_add' => '0000-00-00',
'slug' => '',
'logo' => null,
'featured' => '0',
'twitter' => null,
'fb' => null,
'linkedin' => null,
'youtube' => null,
'app' => false,
'is_career_book' => null,
'why_work_for_us' => null,
'is_blind_applying' => null
),
'Specializations' => array(
'id' => null,
'name' => null
),
'LanguageValue' => array(
'id' => null,
'name' => null,
'short' => null
),
'AvailableCountry' => array(
'idCountry' => '222',
'countryCode' => 'GB',
'countryName' => 'United Kingdom',
'id' => '222'
),
'Entryoption' => array(
'id' => '2',
'name' => 'Job'
),
'Application' => array()
),
'content_for_layout' => '<div class="jobs view">
<div class="row">
<div class="col-md-8 col-sm-8 col-xs-12">
<div class="panel">
<div class="panel-heading">
<div class="panel-title">
<h1 class="pad-top text-thin">Country Manager – United Kingdom</h1>
</div>
</div>
<div class="panel-body">
<h3 class="text-thin">at <strong></strong></h3>
<h4 style="margin-top:4rem;">Details</h4>
<table class="table">
<tbody>
<tr>
<td>
<h5><i class="fa fa-globe pad-rgt"></i> Country</h5>
</td>
<td>United Kingdom</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-comments pad-rgt"></i> Language</h5>
</td>
<td></td>
</tr>
<tr>
<td>
<h5><i class="fa fa-wrench pad-rgt"></i> Specialization</h5>
</td>
<td>
</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-sign-in pad-rgt"></i> Entry Option</h5>
</td>
<td>
Job </td>
</tr>
<tr>
<td>
<h5><i class="fa fa-inbox pad-rgt"></i> Application Period</h5>
</td>
<td>
</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-tag pad-rgt"></i> Tags</h5>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<h4>Description</h4>
Torrent Pharmaceuticals Ltd. (India) / Torrent Pharma GmbH (Germany)
Torrent Pharma GmbH is a wholly owned subsidiary of Torrent pharmaceuticals Limited (TPL) which is a flagship company of ca. EUR 870 million Torrent group in Ahmedabad India. Torrent group is diversified into electrical power and pharmaceuticals.
TPL is a branded generic company manufacturing and selling pharmaceutical products achieving an annual turnover of around EUR 250 million.
R&D capabilities: Invested over EUR 35 million in a modern well equipped state of art research center housing over 600 scientists working on the below mentioned areas of research.
o New Drug Discovery Research (discovering new molecules in niche therapeutic areas)
o New Drug Delivery Systems (proprietary technologies to make value added super generics)
o Generic development (Formulation development and API synthesis, Proven capability to develop non-infringing route and non-infringing formulation)
o BE Centre (state of art Bio-Equivalence centre with 56 beds approved by ANVISA (Brazil) and soon expected to be approved by USFDA and European Health authorities)
Registration capabilities: Highly experienced regulatory team in Germany to support our customers in EU with their dossier registrations strongly backed by an extensive team in India; also providing the flexibility to audit the registration dossiers within EU (Nürnberg, Germany)
Manufacturing capabilities: Our manufacturing facilities (API and formulation), located near Ahmedabad (India), are approved by USFDA and cGMP certified by various authorities including Germany, MHRA (UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
Marketing Presence in Indian Market: Branded Generics company manufacturing and selling pharmaceutical products, achieving an annual turnover of ca. EUR 150 million. Ranked 7th in domestic Rx market; with a field force of over 2200 medical representatives covering over 200,000 doctors. We have a dominant position in therapeutic areas of CNS, CVS (including metabolic disorder), GI, Anti-Microbial, Anti-diabetics, Analgesics and Anti-Inflammatory.
Marketing Presence in International Markets: Exports to more than 70 countries around the world with over 1000 product registrations world wide; wholly owned subsidiaries in USA, Germany, Brazil, Philippines and Russia; own field operations in Germany, Russia & CIS, Lithuania, Brazil, Africa and south east Asia.
We offer:
(1) Product Licensing Co-operation:
- EU CTD registration dossiers with BE studies conducted against EU originator reference, in GCP-GLP certified labs
- Marketing authorizations in key EU countries via national, MRP, DCP procedures
- Supply of products from EU approved (API + Formulation) facilities; vertical integration for most products
- Attractive basket of products in CNS, CVS, GI, GU etc…
(2) New Drug Delivery Systems (NDDS) for value added generics
- Developed unique NDDS platforms which would help to extend the lifespan of existing products.
- Proprietary technology platforms like DuReIn tech, ComTab tech, Gastro Retentive System
- Non Proprietary technology platforms like Taste masking particles, Bi-layered tablets, Mouth dissolving tablets to address needs of patients.
- Novel, Attractive solutions like LAM disp OD formulation – first time in world
(3) Manufacturing Capabilities (Contract Manufacturing)
- Manufacturing facilities (API and formulation) approved by USFDA and cGMP certified by various authorities including Germany, MHRA(UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
- Available capacity of 6 billion tabs / caps / vials per annum
(4) API development and production
- Proven Skills in Medicinal Chemistry, development of non-infringing routes and preparation / submission of DMFs
- R&D Centre well equipped for process development, scale-up and transfer to plant scale production
- Expertise in developing niche APIs, Specially high value, low volume products
- EU approved API manufacturing facilities; capacities being further expanded
Hence in short, we offer you a “one stop shop </div>
<div class="panel-footer">
</div>
</div>
</div>
<div class="col-md-4 col-sm-4 col-xs-12">
<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-70430335-1', 'auto');
ga('send', 'pageview');
</script>
<!-- Signup if not logged in -->
<!-- ======================= -->
<div class="panel panel-bordered-success">
<div class="panel-heading">
<h3 class="panel-title">Join iHipo!</h3>
</div>
<div class="panel-body">
<p>Join the iHipo community for international high potentials and discover new opportunities everyday.</p>
<p class="text-2x mar-no text-center">
<a href="/signup" class="btn btn-info btn-lg btn-rounded"><i class="fa fa-plus"></i> Signup for free</a>
</p>
</div>
</div>
<!-- ======================= -->
</div>
</div>
</div>',
'scripts_for_layout' => '',
'title_for_layout' => 'Country Manager – United Kingdom - Careers, Jobs, Internships, Graduate Programs on iHipo'
)
$userData = null
$job = array(
'Job' => array(
'id' => '1897',
'name' => 'Country Manager – United Kingdom',
'overview' => 'Torrent Pharmaceuticals Ltd. (India) / Torrent Pharma GmbH (Germany)
Torrent Pharma GmbH is a wholly owned subsidiary of Torrent pharmaceuticals Limited (TPL) which is a flagship company of ca. EUR 870 million Torrent group in Ahmedabad India. Torrent group is diversified into electrical power and pharmaceuticals.
TPL is a branded generic company manufacturing and selling pharmaceutical products achieving an annual turnover of around EUR 250 million.
R&D capabilities: Invested over EUR 35 million in a modern well equipped state of art research center housing over 600 scientists working on the below mentioned areas of research.
o New Drug Discovery Research (discovering new molecules in niche therapeutic areas)
o New Drug Delivery Systems (proprietary technologies to make value added super generics)
o Generic development (Formulation development and API synthesis, Proven capability to develop non-infringing route and non-infringing formulation)
o BE Centre (state of art Bio-Equivalence centre with 56 beds approved by ANVISA (Brazil) and soon expected to be approved by USFDA and European Health authorities)
Registration capabilities: Highly experienced regulatory team in Germany to support our customers in EU with their dossier registrations strongly backed by an extensive team in India; also providing the flexibility to audit the registration dossiers within EU (Nürnberg, Germany)
Manufacturing capabilities: Our manufacturing facilities (API and formulation), located near Ahmedabad (India), are approved by USFDA and cGMP certified by various authorities including Germany, MHRA (UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
Marketing Presence in Indian Market: Branded Generics company manufacturing and selling pharmaceutical products, achieving an annual turnover of ca. EUR 150 million. Ranked 7th in domestic Rx market; with a field force of over 2200 medical representatives covering over 200,000 doctors. We have a dominant position in therapeutic areas of CNS, CVS (including metabolic disorder), GI, Anti-Microbial, Anti-diabetics, Analgesics and Anti-Inflammatory.
Marketing Presence in International Markets: Exports to more than 70 countries around the world with over 1000 product registrations world wide; wholly owned subsidiaries in USA, Germany, Brazil, Philippines and Russia; own field operations in Germany, Russia & CIS, Lithuania, Brazil, Africa and south east Asia.
We offer:
(1) Product Licensing Co-operation:
- EU CTD registration dossiers with BE studies conducted against EU originator reference, in GCP-GLP certified labs
- Marketing authorizations in key EU countries via national, MRP, DCP procedures
- Supply of products from EU approved (API + Formulation) facilities; vertical integration for most products
- Attractive basket of products in CNS, CVS, GI, GU etc…
(2) New Drug Delivery Systems (NDDS) for value added generics
- Developed unique NDDS platforms which would help to extend the lifespan of existing products.
- Proprietary technology platforms like DuReIn tech, ComTab tech, Gastro Retentive System
- Non Proprietary technology platforms like Taste masking particles, Bi-layered tablets, Mouth dissolving tablets to address needs of patients.
- Novel, Attractive solutions like LAM disp OD formulation – first time in world
(3) Manufacturing Capabilities (Contract Manufacturing)
- Manufacturing facilities (API and formulation) approved by USFDA and cGMP certified by various authorities including Germany, MHRA(UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
- Available capacity of 6 billion tabs / caps / vials per annum
(4) API development and production
- Proven Skills in Medicinal Chemistry, development of non-infringing routes and preparation / submission of DMFs
- R&D Centre well equipped for process development, scale-up and transfer to plant scale production
- Expertise in developing niche APIs, Specially high value, low volume products
- EU approved API manufacturing facilities; capacities being further expanded
Hence in short, we offer you a “one stop shop',
'date_add' => null,
'company_id' => '2286',
'specialization_id' => null,
'language_value_id' => null,
'available_country_id' => '222',
'entryoption_id' => '2',
'slug' => '',
'status' => '1',
'www' => null,
'tags' => null,
'date_exp' => null,
'featured' => '0',
'meta_title' => '',
'meta_description' => ''
),
'Company' => array(
'id' => '2286',
'epid' => '0',
'name' => '',
'industry_id' => null,
'premium' => '0',
'address' => '',
'zip' => '',
'city' => '',
'available_country_id' => '0',
'email' => 'ankurjauhari@torrentpharma.com',
'www' => '',
'overview' => '',
'status' => '0',
'date_add' => '0000-00-00',
'slug' => '',
'logo' => null,
'featured' => '0',
'twitter' => null,
'fb' => null,
'linkedin' => null,
'youtube' => null,
'app' => false,
'is_career_book' => null,
'why_work_for_us' => null,
'is_blind_applying' => null
),
'Specializations' => array(
'id' => null,
'name' => null
),
'LanguageValue' => array(
'id' => null,
'name' => null,
'short' => null
),
'AvailableCountry' => array(
'idCountry' => '222',
'countryCode' => 'GB',
'countryName' => 'United Kingdom',
'id' => '222'
),
'Entryoption' => array(
'id' => '2',
'name' => 'Job'
),
'Application' => array()
)
$content_for_layout = '<div class="jobs view">
<div class="row">
<div class="col-md-8 col-sm-8 col-xs-12">
<div class="panel">
<div class="panel-heading">
<div class="panel-title">
<h1 class="pad-top text-thin">Country Manager – United Kingdom</h1>
</div>
</div>
<div class="panel-body">
<h3 class="text-thin">at <strong></strong></h3>
<h4 style="margin-top:4rem;">Details</h4>
<table class="table">
<tbody>
<tr>
<td>
<h5><i class="fa fa-globe pad-rgt"></i> Country</h5>
</td>
<td>United Kingdom</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-comments pad-rgt"></i> Language</h5>
</td>
<td></td>
</tr>
<tr>
<td>
<h5><i class="fa fa-wrench pad-rgt"></i> Specialization</h5>
</td>
<td>
</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-sign-in pad-rgt"></i> Entry Option</h5>
</td>
<td>
Job </td>
</tr>
<tr>
<td>
<h5><i class="fa fa-inbox pad-rgt"></i> Application Period</h5>
</td>
<td>
</td>
</tr>
<tr>
<td>
<h5><i class="fa fa-tag pad-rgt"></i> Tags</h5>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<h4>Description</h4>
Torrent Pharmaceuticals Ltd. (India) / Torrent Pharma GmbH (Germany)
Torrent Pharma GmbH is a wholly owned subsidiary of Torrent pharmaceuticals Limited (TPL) which is a flagship company of ca. EUR 870 million Torrent group in Ahmedabad India. Torrent group is diversified into electrical power and pharmaceuticals.
TPL is a branded generic company manufacturing and selling pharmaceutical products achieving an annual turnover of around EUR 250 million.
R&D capabilities: Invested over EUR 35 million in a modern well equipped state of art research center housing over 600 scientists working on the below mentioned areas of research.
o New Drug Discovery Research (discovering new molecules in niche therapeutic areas)
o New Drug Delivery Systems (proprietary technologies to make value added super generics)
o Generic development (Formulation development and API synthesis, Proven capability to develop non-infringing route and non-infringing formulation)
o BE Centre (state of art Bio-Equivalence centre with 56 beds approved by ANVISA (Brazil) and soon expected to be approved by USFDA and European Health authorities)
Registration capabilities: Highly experienced regulatory team in Germany to support our customers in EU with their dossier registrations strongly backed by an extensive team in India; also providing the flexibility to audit the registration dossiers within EU (Nürnberg, Germany)
Manufacturing capabilities: Our manufacturing facilities (API and formulation), located near Ahmedabad (India), are approved by USFDA and cGMP certified by various authorities including Germany, MHRA (UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
Marketing Presence in Indian Market: Branded Generics company manufacturing and selling pharmaceutical products, achieving an annual turnover of ca. EUR 150 million. Ranked 7th in domestic Rx market; with a field force of over 2200 medical representatives covering over 200,000 doctors. We have a dominant position in therapeutic areas of CNS, CVS (including metabolic disorder), GI, Anti-Microbial, Anti-diabetics, Analgesics and Anti-Inflammatory.
Marketing Presence in International Markets: Exports to more than 70 countries around the world with over 1000 product registrations world wide; wholly owned subsidiaries in USA, Germany, Brazil, Philippines and Russia; own field operations in Germany, Russia & CIS, Lithuania, Brazil, Africa and south east Asia.
We offer:
(1) Product Licensing Co-operation:
- EU CTD registration dossiers with BE studies conducted against EU originator reference, in GCP-GLP certified labs
- Marketing authorizations in key EU countries via national, MRP, DCP procedures
- Supply of products from EU approved (API + Formulation) facilities; vertical integration for most products
- Attractive basket of products in CNS, CVS, GI, GU etc…
(2) New Drug Delivery Systems (NDDS) for value added generics
- Developed unique NDDS platforms which would help to extend the lifespan of existing products.
- Proprietary technology platforms like DuReIn tech, ComTab tech, Gastro Retentive System
- Non Proprietary technology platforms like Taste masking particles, Bi-layered tablets, Mouth dissolving tablets to address needs of patients.
- Novel, Attractive solutions like LAM disp OD formulation – first time in world
(3) Manufacturing Capabilities (Contract Manufacturing)
- Manufacturing facilities (API and formulation) approved by USFDA and cGMP certified by various authorities including Germany, MHRA(UK), Hungary, Latvia, Australia, South Africa, Brazil and so on.
- Available capacity of 6 billion tabs / caps / vials per annum
(4) API development and production
- Proven Skills in Medicinal Chemistry, development of non-infringing routes and preparation / submission of DMFs
- R&D Centre well equipped for process development, scale-up and transfer to plant scale production
- Expertise in developing niche APIs, Specially high value, low volume products
- EU approved API manufacturing facilities; capacities being further expanded
Hence in short, we offer you a “one stop shop </div>
<div class="panel-footer">
</div>
</div>
</div>
<div class="col-md-4 col-sm-4 col-xs-12">
<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-70430335-1', 'auto');
ga('send', 'pageview');
</script>
<!-- Signup if not logged in -->
<!-- ======================= -->
<div class="panel panel-bordered-success">
<div class="panel-heading">
<h3 class="panel-title">Join iHipo!</h3>
</div>
<div class="panel-body">
<p>Join the iHipo community for international high potentials and discover new opportunities everyday.</p>
<p class="text-2x mar-no text-center">
<a href="/signup" class="btn btn-info btn-lg btn-rounded"><i class="fa fa-plus"></i> Signup for free</a>
</p>
</div>
</div>
<!-- ======================= -->
</div>
</div>
</div>'
$scripts_for_layout = ''
$title_for_layout = 'Country Manager – United Kingdom - Careers, Jobs, Internships, Graduate Programs on iHipo'
$cakeDescription = 'CakePHP: the rapid development php framework'include - APP/View/Layouts/frontend.ctp, line 230
View::_evaluate() - CORE/Cake/View/View.php, line 948
View::_render() - CORE/Cake/View/View.php, line 910
View::renderLayout() - CORE/Cake/View/View.php, line 542
View::render() - CORE/Cake/View/View.php, line 479
Controller::render() - CORE/Cake/Controller/Controller.php, line 954
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 198
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 165
[main] - APP/webroot/index.php, line 111
